drugset / Trial / NCT07010575
Patient Preference Study: Standard of Care Versus Once-daily Trientine Tetrahydrochloride
NaSingle-groupOpen-labelTreatment
Summary
Decentralized study to assess patient reported treatment satisfaction comparing their current standard-of-care Wilson's Disease (WD) treatment with a new once-daily Trientine (TETA) 4HCl formulation.
Timeline
- Start
- 2025-07-15
- Primary completion
- 2025-12-18
- Completion
- 2025-12-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | trientine | Unknown | 300 mg | — |